Safety and Efficacy of Venetoclax (ABT-199/GDC-0199) in Combination with Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase 1b Results

Bibliographic Details
Title:	Safety and Efficacy of Venetoclax (ABT-199/GDC-0199) in Combination with Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase 1b Results
Authors:	Moreau, Philippe ^, Chanan-Khan, Asher ^, Roberts, Andrew W., Agarwal, Amit B., Facon, Thierry, Kumar, Shaji, Touzeau, Cyrille ^, Darden, David ^, Morris, Lura ^, Ross, Jeremy ^, Salem, Ahmed H ^, Munasinghe, Wijith ^, Zhu, Ming ^, Leverson, Joel ^, Maciag, Paulo ^, Enschede, Sari Heitner ^, Verdugo, Maria ^, Humerickhouse, Rod A., Harrison, Simon ^
Source:	In Blood 3 December 2015 126(23):3038-3038
Database:	ScienceDirect